NR3C2 and obesity due to melanocortin 4 receptor deficiency: Furthermore, both Caprio's group and others have shown that pharmacological MR blockade in mice implies beneficial outcomes on adipose tissue and glucose tolerance, thus combating obesity (12, 13).